Core Aesthetics clinical evidence briefs are topic specific reviews that separate what a study measured from what people may assume it proves. Each brief records the population, exposure, comparator, endpoint, timeframe, funding, limitations and unanswered questions. The briefs support informed consultation, but they are not formal systematic reviews, treatment recommendations or substitutes for individual assessment.
What Is A Clinical Evidence Brief?
A clinical evidence brief answers one defined patient question using the most relevant human research and official guidance available at the review date. It does not begin with a treatment claim. It begins with the question, then records what each source can and cannot establish.
The original papers remain the primary evidence. The clinic brief is an explanation layer designed to make methods, limits and uncertainty easier to inspect before consultation.
The Current Brief
| Brief | Question | Evidence status | Reviewed |
|---|---|---|---|
| 01. Long term masseter effects | What do thickness, density and morphology studies establish about repeated masseter treatment? | One year findings are reassuring within scope; cumulative effects remain uncertain. | 13 July 2026 |
How Evidence Is Weighed
Study design matters, but design alone is not enough. NHMRC guidance also points to certainty, directness and whether the available population, comparison and outcomes answer the actual question. A well run study can still be indirect if the exposure or timeframe is different from real world use.
| Evidence source | What it can add | What still needs checking |
|---|---|---|
| Systematic review or meta analysis | Combines a wider body of evidence | Quality, similarity and size of the included studies |
| Randomised controlled study | Reduces some sources of bias for a defined exposure | Duration, endpoint choice, generalisability and funding |
| Observational study | Can capture longer or less selected real world use | Confounding, selection and measurement quality |
| Case report or patient account | Can identify a possible signal or lived concern | Cannot estimate how common the event is or prove one cause |
Why Measurements Must Stay Separate
Studies may measure density, thickness, volume, symptom scores, photographs or patient reported change. These are related only to the extent that the method supports that connection. An unchanged finding for one endpoint does not automatically settle every other endpoint.
Each brief names the exact measurement before describing the finding. This protects against turning a narrow finding into an absolute safety or outcome statement.
What Is Recorded For Every Paper
- The patient question the paper can help answer.
- Study design, sample size and population.
- Number of sessions, cumulative exposure and follow up time.
- Comparator and prespecified endpoints where reported.
- Main finding in plain English without extending it beyond the measured endpoint.
- Important limitations, missing data and generalisability.
- Funding source and relevant author relationships.
- Trial registration or protocol when one is available.
How Funding And Conflicts Are Handled
Industry funded research can be methodologically strong and clinically useful. Funding does not make a paper false. It does create context that readers should be able to inspect, especially when the sponsor helped design the study, analyse data or review publication.
Evidence briefs name material funding and author relationships. Several papers from one sponsored trial are not described as independent replication.
How Conclusions Are Worded
| Label | Meaning |
|---|---|
| Supported within scope | The available evidence answers the defined endpoint, population and timeframe with reasonable consistency. |
| Uncertain or mixed | Findings differ, evidence is limited, or important indirectness remains. |
| Not answered | The available studies do not measure the real question closely enough. |
| Outside this brief | The question needs another specialty, diagnostic pathway or evidence review. |
These labels describe evidence, not personal suitability. They do not predict an individual outcome.
How Updates And Corrections Work
Every brief shows a review date. Material changes are recorded in a revision table, including citation corrections, new evidence, changed conclusions or important regulatory updates. A changed conclusion should explain why it changed.
If you identify a source error or a material paper that has been missed, use the contact page and include the DOI or official source link. The claim will be checked against the original source rather than a search snippet.
Read the full editorial and evidence policy for authorship, AI assistance, corrections, image standards and commercial disclosure rules.
Who Reviews The Briefs
Clinical relevance and patient facing wording are reviewed for Core Aesthetics by Corey Anderson RN, Ahpra registration NMW0001047575. The reviewer, clinic location, source list and review date are visible so the reader does not have to rely on a generic brand claim.
Corey is not presented as an independent research institute or guideline panel. The brief remains clinic authored education and should be read alongside the original papers.
What These Briefs Cannot Do
An evidence brief cannot diagnose a condition, determine personal suitability or promise an outcome. It cannot turn absent evidence into proof of safety, and it cannot use one small study to predict every person’s long term response.
The safest use is to improve the questions asked in consultation and to make uncertainty visible before a decision is made.
Start With The Masseter Review
Clinical Evidence Brief 01 examines the long term masseter question. It separates cortical thickness, density and morphology, shows that two later papers came from the same trial, records manufacturer funding and explains why one or two sessions over twelve months cannot answer many cycles over several years.
For the broader decision pathway, continue to patient safety, regulation and scope, treatment suitability assessment and why a practitioner may recommend no treatment.
Sources And Review Standards
- NHMRC guidance on assessing certainty of evidence
- Ahpra guidelines for registered health practitioners who perform non surgical cosmetic procedures
- TGA guidance for advertising health services involving therapeutic goods
- Journal of Oral Rehabilitation, 2024, doi:10.1111/joor.13590
- Aesthetic Surgery Journal, 2025, doi:10.1093/asj/sjaf167
- Aesthetic Surgery Journal, 2026, doi:10.1093/asj/sjag080
- Clinical trial record NCT02010775
Is this for you?
Consider booking a consultation if
- Adults who want to inspect how Core Aesthetics summarises clinical research
- Readers comparing study design, endpoints, timeframe and funding before consultation
- People who want direct links to primary papers and official Australian guidance
- People who prefer uncertainty and corrections to be stated explicitly
This may not be for you if
- People seeking a personal diagnosis or treatment recommendation from an article
- Readers expecting a formal systematic review or clinical practice guideline
- People who want research summaries to replace individual assessment
- People seeking a fixed treatment outcome from an article
Suitability is confirmed at consultation. This list is general guidance, not a substitute for clinical assessment.
Frequently asked questions
What is a Core Aesthetics clinical evidence brief?
It is a topic specific clinic review that explains what selected research measured, what it found, where it is limited and how cautiously the finding can be applied. Each brief records review dates, key sources, endpoints, timeframe, funding context and unanswered questions. It supports consultation but does not replace personal assessment.
Is a clinical evidence brief a formal systematic review?
No. Core Aesthetics evidence briefs are structured clinic education, not formal systematic reviews, clinical practice guidelines or independent evidence grading exercises. The methods and limits are stated so readers can judge the scope. The original papers and official sources remain the primary evidence.
How are studies chosen for an evidence brief?
The review starts with recent human systematic reviews, controlled studies, registered trial records and relevant Australian guidance. A paper is included when it directly helps answer the page question. Selection is not based on whether the finding supports treatment, and contrary or uncertain evidence is kept visible.
Why are study endpoints listed separately?
Different endpoints can answer different questions. Bone density, cortical thickness, muscle volume, symptom scores and visible facial changes are not interchangeable. Listing each endpoint prevents a narrow result from being stretched into a broader safety or outcome claim.
Why does funding appear in the evidence table?
Funding and author relationships can affect study design, endpoint selection, analysis and interpretation. Industry funding does not automatically invalidate research, but readers should be able to see it. Independent replication is more persuasive than several publications drawn from one sponsored trial.
How often are clinical evidence briefs reviewed?
Each brief displays its review date and revision history. A brief should be reviewed when a material new study, safety notice or regulatory change appears, and during the clinic content review cycle. If the conclusion changes, the reason should be recorded rather than silently replacing the earlier wording.
Does an evidence brief recommend treatment?
No. It explains the research question and its limits. A personal decision still depends on health history, anatomy, goals, previous treatment, risk, timing and clinical assessment. Booking does not make treatment automatic, and a consultation can end with education, waiting, referral or no treatment.
Who reviews Core Aesthetics evidence briefs?
Clinical relevance and patient facing wording are reviewed for Core Aesthetics by Corey Anderson RN, Ahpra registration NMW0001047575. Readers can verify the practitioner independently. The brief also names its limits so the clinic reviewer is not presented as an independent research organisation or guideline body.